APA (7th ed.) Citation

A, S., EM, G., K, G., B, S., AEZ, S., O, L., . . . YKO, T. (2024). Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial. Arthritis & rheumatology (Hoboken, N.J.), 76(1), 59. https://doi.org/10.1002/art.42657

Chicago Style (17th ed.) Citation

A, Saxena, et al. "Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial." Arthritis & Rheumatology (Hoboken, N.J.) 76, no. 1 (2024): 59. https://doi.org/10.1002/art.42657.

MLA (9th ed.) Citation

A, Saxena, et al. "Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial." Arthritis & Rheumatology (Hoboken, N.J.), vol. 76, no. 1, 2024, p. 59, https://doi.org/10.1002/art.42657.